Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers in our Department working on Motor Neuron Disease (MND) do the Ice Bucket Challenge, which has taken the internet by storm this week and so far raised £6 million.

The team wanted to do their bit to raise money for research into this devastating disease. From left to right they are: Lucy Farrimond, David Gordon, Louisa Kent, Jakub Scaber, Kevin Talbot, Martin Turner and Thomas Vizard. 

It was great to take part in the Ice Bucket Challenge. It raises awareness for a devastating disease and I hope people will continue to donate to help us find a cure for Motor Neuron Disease. - Professor Kevin Talbot

MND is a rapidly progressive and fatal disease, which can affect any adult at any time and attacks the motor neurones that send messages from the brain to the muscles, leaving people unable to walk, talk or feed themselves.

The cause of the disease is currently unknown and there is no known cure. Around 5,000 people in the UK have MND at any one time, with half of people with the disease dying within 14 months of diagnosis. It kills five people every day in the UK.

Research in the Oxford Motor Neuron Disease Centre aims to improve understanding of motor neuron diseases, principally amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), to find treatments to improve the lives of patients with these currently incurable conditions.

The Motor Neurone Disease (MND) Association  funds research to understand what causes MND, how to diagnose it and, most importantly, how to effectively treat it so that it no longer devastates lives.

Denise Davies, Head of Community Fundraising at the MND Association, said: “Without the amazing support of people who contribute, the Association simply would not be able to provide its vital support services and fund research to find a cure. Together we are making a real difference for people affected by this devastating disease.”

Donate by visiting www.mndassociation.org or text ICED55 (with amount of your donation)

Similar stories

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.

Collaboration with the Nepal Public Health Foundation (NPHF) explores maternal health and epilepsy

A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.